AbbVie (ABBV) Payables (2012 - 2026)
AbbVie's Payables was $33.3 billion in Q2 2026, down 11.9% from $37.8 billion a year earlier and down 1.4% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Payables (2012 - 2026) Analysis & Trends
At the end of FY2025, Payables at AbbVie came in at $37.23 billion, up 16.6% from FY2024.
- Payables has now increased for six consecutive years, with a five-year compound annual growth rate of 13.0% (FY2020 to FY2025).
- In earlier years, Payables was $31.95 billion in FY2024 (+4.2%), $30.65 billion in FY2023 (+20.7%), $25.4 billion in FY2022 (+11.8%) and $22.71 billion in FY2021 (+12.5%).
- The Q2 2026 figure marks the lowest quarterly Payables since Q1 2025.
- Compared with a year earlier, Payables was higher in seven of the last eight quarters, with growth averaging 8.9%.
- The best year-over-year quarter for Payables over five years was Q2 2025 (growth of 28.9%); the worst was Q2 2026 (a decline of 11.9%).
- Per Business Quant data, ABBV's Payables in the three quarters before Q2 2026 was $33.77 billion (Q1 2026), $37.23 billion (Q4 2025) and $37.41 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 4.16 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.30 Bn |
| Mar 31, 2026 | 33.77 Bn |
| Dec 31, 2025 | 37.23 Bn |
| Sep 30, 2025 | 37.41 Bn |
| Jun 30, 2025 | 37.80 Bn |
| Mar 31, 2025 | 32.63 Bn |
| Dec 31, 2024 | 31.95 Bn |
| Sep 30, 2024 | 30.49 Bn |
| Jun 30, 2024 | 29.33 Bn |
| Mar 31, 2024 | 31.33 Bn |
| Dec 31, 2023 | 30.65 Bn |
| Sep 30, 2023 | 29.66 Bn |
| Jun 30, 2023 | 27.04 Bn |
| Mar 31, 2023 | 24.79 Bn |
| Dec 31, 2022 | 25.40 Bn |
| Sep 30, 2022 | 23.52 Bn |
| Jun 30, 2022 | 22.56 Bn |
| Mar 31, 2022 | 22.58 Bn |
| Dec 31, 2021 | 22.71 Bn |
| Sep 30, 2021 | 21.88 Bn |
API Access
AbbVie Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();